Stephen Kennedy
Chief Tech/Sci/R&D Officer at CRISPR THERAPEUTICS AG
Profile
Stephen R. Kennedy occupies the position of Head-Technical Operations at CRISPR Therapeutics AG. In his past career Mr. Kennedy held the position of Executive Vice President-Research & Development at Mascoma Corp., Senior Vice President & Head-Technical Operations at Casebia Therapeutics LLC, Principal at Eastman Kodak Co., Chief Operating Officer & Executive Vice President of Histogenics Corp., Principal at Genencor International, Inc., Senior VP-Biologics Technical Operations at Genzyme Corp. and Executive Director-MIT Center at Massachusetts Institute of Technology. Stephen R. Kennedy received an MBA from Boston University, a graduate degree from the University of Rochester and an undergraduate degree from the University of Michigan.
Stephen Kennedy active positions
Companies | Position | Start |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Former positions of Stephen Kennedy
Companies | Position | End |
---|---|---|
OCUGEN, INC. | Chief Operating Officer | 2019-03-21 |
Mascoma Corp.
Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 2013-07-31 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 2011-04-30 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2009-12-31 |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Corporate Officer/Principal | 1991-12-31 |
Training of Stephen Kennedy
Rochester Christian University | Graduate Degree |
Boston University | Masters Business Admin |
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EASTMAN KODAK COMPANY | Producer Manufacturing |
CRISPR THERAPEUTICS AG | Health Technology |
Private companies | 7 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Mascoma Corp.
Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Health Technology |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Sweet Natural Trading Co. Ltd.
Sweet Natural Trading Co. Ltd. Food: Specialty/CandyConsumer Non-Durables Sweet Natural Trading Co. Ltd. engages in the provision of consumer-packaged goods with natural sweetener-based products such as xylitol and coconut sugar. It operates through the Canada and United States geographical segments. It offers candies; bread; cereal; snacks; dips and spreads; drinks; condiments, dressing, and sauces; baking products, pasta, and chocolate. The company was founded by Andrew Reid and Julie Reid in 2004 and is headquartered in Toronto, Canada. | Consumer Non-Durables |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Stephen Kennedy